HemOnc Today


The following articles appeared in the print edition of HEMONC TODAY.

Table of Contents
Cover Story

Minimally invasive cervical cancer surgery may promote disease recurrence; professionals urge patience


Would more aggressive adjuvant therapy following minimally invasive surgery help close the survival gap with open surgery?


Second opinions in oncology: Reducing frustration

John Sweetenham, MD


Personalized context of the cancer cell

Sofia D. Merajver, MD, PhD

Meeting News

Adjuvant capecitabine fails to extend survival in early-stage triple-negative breast cancer

Gut microbial diversity before stem cell transplantation may impact survival

Racial disparities seen in supportive care use among patients with multiple myeloma

Rapid assignment of molecularly driven treatment feasible for acute myeloid leukemia

Some elderly patients with breast cancer less likely to receive adjuvant chemotherapy despite OS benefit

Triplet therapy shows promise in relapsed, refractory Hodgkin lymphoma

In the Journals Plus

Guideline-driven treatment fails to prolong OS among younger patients with rectal cancer

Vaccine, nivolumab combination appears promising in recurrent HPV-related cancer

Immediate compression offers 'clear benefit' following blood clot

Immune checkpoint inhibitors associated with range of cardiovascular toxicities

Liquid biopsy improves detection of targetable mutations in non-small cell lung cancer

FDA News

FDA approves Ultomiris for paroxysmal nocturnal hemoglobinuria

FDA grants orphan drug designation to M7824 for biliary tract cancer

FDA approves Herzuma, biosimilar to Herceptin, for breast cancer subset

FDA approves romiplostim for children with immune thrombocytopenia

FDA approves Elzonris for blastic plasmacytoid dendritic cell neoplasm

FDA approves Asparlas for acute lymphoblastic leukemia

FDA grants CRISPR gene therapy fast track designation for sickle cell disease